Results 111 to 120 of about 210,681 (329)

Future of smart cardiovascular implants [PDF]

, 2018
Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav, Mercer, John R., Neale, Steven   +2 more
core   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

Localization of Left Ventricular Lead Electrodes in Relation to Myocardial Scar in Patients Undergoing Cardiac Resynchronization Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background The efficacy of cardiac resynchronization therapy may be reduced in the event of pacing within myocardial fibrosis. We aimed to develop a method to determine the anatomical relationships between the left ventricular (LV) lead and myocardial ...
Arnaud Bisson, Julien Pucheux, Clémentine Andre, Anne Bernard, Bertrand Pierre, Dominique Babuty, Laurent Fauchier, Nicolas Clementy   +7 more
doaj   +1 more source

Machine learning‐based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy

European Journal of Heart Failure, 2018
We tested the hypothesis that a machine learning (ML) algorithm utilizing both complex echocardiographic data and clinical parameters could be used to phenogroup a heart failure (HF) cohort and identify patients with beneficial response to cardiac ...
M. Čikeš, S. Sánchez-Martínez, B. Claggett, N. Duchateau, G. Piella, C. Butakoff, A. Pouleur, D. Knappe, T. Biering-Sørensen, V. Kutyifa, A. Moss, K. Stein, S. Solomon, B. Bijnens   +13 more
semanticscholar   +1 more source

Left bundle branch area pacing delivery of cardiac resynchronization therapy and comparison with biventricular pacing

ESC Heart Failure, 2020
This multicentre observational study aimed to prospectively assess the efficacy of left bundle branch area pacing (LBBAP) in heart failure patients with left bundle branch block (LBBB) and compare the 6‐month outcomes between LBBAP and biventricular ...
Xiaofei Li, C. Qiu, R. Xie, Wentao Ma, Zhao Wang, Hui Li, Hao Wang, W. Hua, Shu Zhang, Yan Yao, Xiaohan Fan   +10 more
semanticscholar   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source

Cardiac resynchronization therapy: Femoral approach

Revista Portuguesa de Cardiologia, 2017
We describe the case of a 62-year-old female patient with bilateral subclavian vein occlusion, in whom a cardiac resynchronization system was implanted via a femoral vein.
Luís Brandão, Rita Miranda, Sofia Almeida, Luciano Ribeiro, Carlos Alvarenga, Isabel João, Hélder Pereira   +6 more
doaj   +1 more source

Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I.

European Heart Journal, 2019
AIMS To assess the impact of MultiPoint™ Pacing (MPP)-programmed according to the physician's discretion-in non-responders to standard biventricular pacing after 6 months.
C. Leclercq, H. Burri, A. Curnis, P. Delnoy, C. Rinaldi, J. Sperzel, Kwangdeok Lee, L. Calò, A. Vicentini, J. F. Concha, B. Thibault   +10 more
semanticscholar   +1 more source

Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial [PDF]

, 2017
BackgroundData from randomized trials have suggested a modest or no effect of conventional cardiac resynchronization therapy (convCRT) on the incidence of atrial fibrillation (AF).
Aonuma Kazutaka, Birnie David, Cerkvenik Jeffrey, Gasparini Maurizio, Gorcsan John, Hudnall Harrison, Lee Kathy Lai-Fun, Lemke Bernd, Martin David O., 青沼 和隆   +9 more
core   +2 more sources

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source